Subsolid Lung Nodules: Potential for Overdiagnosis.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Assessment of risk factors in persistent subsolid pulmonary nodules based on CT dynamic follow-up.BMC medical imaging · 2026
   Article
2. OM-85, a Bacterial Lysate, Reduces Pulmonary Nodule Malignant Probability: A Retrospective Study.The clinical respiratory journal · 2025
   Article
3. Radiomics in Early Lung Cancer Diagnosis: From Diagnosis to Clinical Decision Support and Education.Diagnostics (Basel, Switzerland) · 2022
   Review
4. Impact of Smoking Status on Lung Cancer Characteristics and Mortality Rates between Screened and Non-Screened Lung Cancer Cohorts: Real-World Knowledge Translation and Education.Journal of personalized medicine · 2022
   Article
5. Implementation of artificial intelligence in the histological assessment of pulmonary subsolid nodules.Translational lung cancer research · 2021
   Article

Corrections and comments

• Comment on
  Cancer Risk in Subsolid Nodules in the National Lung Screening Trial.2019

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as